Bioceltix S.A.
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company's products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells … Read more
Bioceltix S.A. (BCX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.184x
Based on the latest financial reports, Bioceltix S.A. (BCX) has a cash flow conversion efficiency ratio of -0.184x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-4.97 Million) by net assets (zł27.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioceltix S.A. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Bioceltix S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioceltix S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioceltix S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xaar plc
PINK:XAARF
|
-0.016x |
|
Action Electronics Co Ltd
TW:3024
|
-0.039x |
|
CropEnergies AG
HM:CE2
|
0.099x |
|
Austriacard Holdings AG
F:ACQ0
|
0.060x |
|
Immsi S.p.A
F:IMY
|
0.148x |
|
PetroShale Inc
OTCQB:PSHIF
|
0.042x |
|
Seoyon Co Ltd
KO:007860
|
0.053x |
|
JSL S.A
SA:JSLG3
|
0.419x |
Annual Cash Flow Conversion Efficiency for Bioceltix S.A. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Bioceltix S.A. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł38.42 Million | zł-17.74 Million | -0.462x | +67.23% |
| 2023-12-31 | zł10.47 Million | zł-14.75 Million | -1.409x | +37.89% |
| 2022-12-31 | zł3.48 Million | zł-7.91 Million | -2.269x | -236.88% |
| 2021-12-31 | zł6.00 Million | zł-4.04 Million | -0.673x | -47.99% |
| 2020-12-31 | zł3.32 Million | zł-1.51 Million | -0.455x | +48.07% |
| 2019-12-31 | zł1.91 Million | zł-1.67 Million | -0.876x | +22.89% |
| 2018-12-31 | zł1.57 Million | zł-1.79 Million | -1.136x | -- |